Edition:
United States

Pharmaceuticals

Aceto Corp Says Bankruptcy Court Entered Order Confirming Second Modified Joint Plan Of Its Liquidation

Sept 20 (Reuters) - Aceto Corp ::ACETO CORP SAYS ON SEPTEMBER 18 BANKRUPTCY COURT ENTERED ORDER CONFIRMING SECOND MODIFIED JOINT PLAN OF LIQUIDATION OF CO - SEC FILING.

Friday, 20 Sep 2019 04:59pm EDT

Fitch Says U.S. Collateralized Loan Obligations Fairly Insulated From Pharma Sector's Opioid Issue

Sept 20 (Reuters) - Fitch::FITCH SAYS U.S. COLLATERALIZED LOAN OBLIGATIONS FAIRLY INSULATED FROM PHARMA SECTOR'S OPIOID ISSUE.FITCH - VIEWS SETTLEMENT AGREEMENTS REACHED BY MALLINCKRODT, ENDO AS POSITIVE DEVELOPMENTS BUT THIS DOES NOT ELIMINATE ALL PENDING OPIOID LITIGATION.FITCH - VIEWS EFFECT OF...

Friday, 20 Sep 2019 12:14pm EDT

Fitch Says U.S. Collateralized Loan Obligations Fairly Insulated From Pharma Sector's Opioid Issue

Sept 20 (Reuters) - Fitch::FITCH SAYS U.S. COLLATERALIZED LOAN OBLIGATIONS FAIRLY INSULATED FROM PHARMA SECTOR'S OPIOID ISSUE.FITCH - VIEWS SETTLEMENT AGREEMENTS REACHED BY MALLINCKRODT, ENDO AS POSITIVE DEVELOPMENTS BUT THIS DOES NOT ELIMINATE ALL PENDING OPIOID LITIGATION.FITCH - VIEWS EFFECT OF...

Friday, 20 Sep 2019 12:14pm EDT

Novo Nordisk Says FDA Approves Rybelsus, The First GLP-1 Analog Treatment Available In A Pill For Adults With Type 2 Diabetes

Sept 20 (Reuters) - Novo Nordisk A/S ::FDA APPROVES RYBELSUS® (SEMAGLUTIDE), THE FIRST GLP-1 ANALOG TREATMENT AVAILABLE IN A PILL FOR ADULTS WITH TYPE 2 DIABETES.NOVO NORDISK - FDA STILL REVIEWING NDA FOR RYBELSUS TO REDUCE MAJOR ADVERSE CARDIOVASCULAR EVENTS RISK IN ADULTS WITH TYPE 2 DIABETES,...

Friday, 20 Sep 2019 10:49am EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.